Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3776709011 | Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3776710018 | Anthraquinone glycoside and salicylic acid only product in oromucosal dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Has manufactured dose form | Oromucosal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Is a | Product containing only anthraquinone glycoside and salicylic acid (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Is a | Product containing anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Has active ingredient | Anthraquinone glycoside | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Has active ingredient | Salicylic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Plays role | Antifungal therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Is a | True | Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR